These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 17306536
1. Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1. Wheeler TM, Krym MC, Thornton CA. Neuromuscul Disord; 2007 Mar; 17(3):242-7. PubMed ID: 17306536 [Abstract] [Full Text] [Related]
2. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features. Dansithong W, Wolf CM, Sarkar P, Paul S, Chiang A, Holt I, Morris GE, Branco D, Sherwood MC, Comai L, Berul CI, Reddy S. PLoS One; 2008 Mar; 3(12):e3968. PubMed ID: 19092997 [Abstract] [Full Text] [Related]
3. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. Ho TH, Savkur RS, Poulos MG, Mancini MA, Swanson MS, Cooper TA. J Cell Sci; 2005 Jul 01; 118(Pt 13):2923-33. PubMed ID: 15961406 [Abstract] [Full Text] [Related]
4. RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy. Sobczak K, Wheeler TM, Wang W, Thornton CA. Mol Ther; 2013 Feb 01; 21(2):380-7. PubMed ID: 23183533 [Abstract] [Full Text] [Related]
5. Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain. Suenaga K, Lee KY, Nakamori M, Tatsumi Y, Takahashi MP, Fujimura H, Jinnai K, Yoshikawa H, Du H, Ares M, Swanson MS, Kimura T. PLoS One; 2012 Feb 01; 7(3):e33218. PubMed ID: 22427994 [Abstract] [Full Text] [Related]
6. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1. de Haro M, Al-Ramahi I, De Gouyon B, Ukani L, Rosa A, Faustino NA, Ashizawa T, Cooper TA, Botas J. Hum Mol Genet; 2006 Jul 01; 15(13):2138-45. PubMed ID: 16723374 [Abstract] [Full Text] [Related]
7. Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy. Leger AJ, Mosquea LM, Clayton NP, Wu IH, Weeden T, Nelson CA, Phillips L, Roberts E, Piepenhagen PA, Cheng SH, Wentworth BM. Nucleic Acid Ther; 2013 Apr 01; 23(2):109-17. PubMed ID: 23308382 [Abstract] [Full Text] [Related]
8. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. Wang GS, Kearney DL, De Biasi M, Taffet G, Cooper TA. J Clin Invest; 2007 Oct 01; 117(10):2802-11. PubMed ID: 17823658 [Abstract] [Full Text] [Related]
9. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms. Jenquin JR, Coonrod LA, Silverglate QA, Pellitier NA, Hale MA, Xia G, Nakamori M, Berglund JA. ACS Chem Biol; 2018 Sep 21; 13(9):2708-2718. PubMed ID: 30118588 [Abstract] [Full Text] [Related]
10. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Osborne RJ, Lin X, Welle S, Sobczak K, O'Rourke JR, Swanson MS, Thornton CA. Hum Mol Genet; 2009 Apr 15; 18(8):1471-81. PubMed ID: 19223393 [Abstract] [Full Text] [Related]
11. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels. Reddy K, Jenquin JR, McConnell OL, Cleary JD, Richardson JI, Pinto BS, Haerle MC, Delgado E, Planco L, Nakamori M, Wang ET, Berglund JA. Proc Natl Acad Sci U S A; 2019 Oct 15; 116(42):20991-21000. PubMed ID: 31570586 [Abstract] [Full Text] [Related]
12. Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila. Houseley JM, Wang Z, Brock GJ, Soloway J, Artero R, Perez-Alonso M, O'Dell KM, Monckton DG. Hum Mol Genet; 2005 Mar 15; 14(6):873-83. PubMed ID: 15703191 [Abstract] [Full Text] [Related]
13. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy. Wojtkowiak-Szlachcic A, Taylor K, Stepniak-Konieczna E, Sznajder LJ, Mykowska A, Sroka J, Thornton CA, Sobczak K. Nucleic Acids Res; 2015 Mar 31; 43(6):3318-31. PubMed ID: 25753670 [Abstract] [Full Text] [Related]
14. Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor. Wong CH, Nguyen L, Peh J, Luu LM, Sanchez JS, Richardson SL, Tuccinardi T, Tsoi H, Chan WY, Chan HY, Baranger AM, Hergenrother PJ, Zimmerman SC. J Am Chem Soc; 2014 Apr 30; 136(17):6355-61. PubMed ID: 24702247 [Abstract] [Full Text] [Related]
15. Loss of MBNL1-mediated retrograde BDNF signaling in the myotonic dystrophy brain. Wang PY, Kuo TY, Wang LH, Liang WH, Wang GS. Acta Neuropathol Commun; 2023 Mar 15; 11(1):44. PubMed ID: 36922901 [Abstract] [Full Text] [Related]
16. Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy. Sznajder ŁJ, Swanson MS. Int J Mol Sci; 2019 Jul 09; 20(13):. PubMed ID: 31323950 [Abstract] [Full Text] [Related]
17. In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models. García-López A, Llamusí B, Orzáez M, Pérez-Payá E, Artero RD. Proc Natl Acad Sci U S A; 2011 Jul 19; 108(29):11866-71. PubMed ID: 21730182 [Abstract] [Full Text] [Related]
18. RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1. Lee JE, Bennett CF, Cooper TA. Proc Natl Acad Sci U S A; 2012 Mar 13; 109(11):4221-6. PubMed ID: 22371589 [Abstract] [Full Text] [Related]
19. A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1. Jahromi AH, Nguyen L, Fu Y, Miller KA, Baranger AM, Zimmerman SC. ACS Chem Biol; 2013 May 17; 8(5):1037-43. PubMed ID: 23480597 [Abstract] [Full Text] [Related]
20. Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy. Wang PY, Lin YM, Wang LH, Kuo TY, Cheng SJ, Wang GS. Hum Mol Genet; 2017 Jun 15; 26(12):2247-2257. PubMed ID: 28369378 [Abstract] [Full Text] [Related] Page: [Next] [New Search]